Cysteine proteinase SpeB from Streptococcus pyogenes-A potent modifier of immunologically important host and bacterial proteins

Biological Chemistry

Volumn 392, Issue 12, 2011, Pages 1077-1088

  Nelson, Daniel C ^a,b   Garbe, Julia ^c   Collin, Mattias ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Animal models; C10 cysteine proteinase; Human infection; Immune evasion; Proteolysis; SpeB; Streptococcal cysteine proteinase; Streptopain; Virulence

Indexed keywords

BACTERIAL PROTEIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE SPEB; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STREPTOCOCCUS PYOGENES;

ANIMALS; BACTERIAL PROTEINS; EXOTOXINS; HUMANS;

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 80755169615     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.208     Document Type: Review

References (93)

1. Allhorn, M., Olsén, A., and Collin, M. (2008). EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity. BMC Microbiol. 8 , 3
2. Ashbaugh, C.D. and Wessels, M.R. (2001). Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect. Immun. 69 , 6683-6688. (Pubitemid 32995424)
3. Ashbaugh, C.D., Warren, H.B., Carey, V.J., and Wessels, M.R. (1998). Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Invest. 102 , 550-560. (Pubitemid 28376158)
4. Aziz, R., Pabst, M., Jeng, A., Kansal, R., Low, D., Nizet, V., and Kotb, M. (2004). Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol. Microbiol. 51 , 123-134. (Pubitemid 38031076)
5. Baggiolini, M. (2001). Chemokines in pathology and medicine. J. Intern. Med. 250 , 91-104. (Pubitemid 32868689)
6. Berge, A. and Bj ö rck, L. (1995). Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J. Biol. Chem. 270 , 9862-9867.
7. Berge, A., Kihlberg, B.-M., Sj ö holm, A., and Bj ö rck, L. (1997). Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgGcoated targets. J. Biol. Chem. 272 , 20774-20781. (Pubitemid 27355644)
8. Bj ö rck, L., A kesson, P., Bohus, M., Trojnar, J., Abrahamson, M., Olafsson, I., and Grubb, A. (1989). Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 337 , 385-386. (Pubitemid 19043503)
9. Bober, M., Mörgelin, M., Olin, A.I., von Pawel-Rammingen, U., and Collin, M. (2011). The membrane bound LRR lipoprotein Slr, and the cell wall-anchored M1 protein from Streptococcus pyogenes both interact with type I collagen. PLoS ONE 6 , e20345.
10. Bohach, G.A., Hauser, A.R., and Schlievert, P.M. (1988). Cloning of the gene, speB , for streptococcal pyrogenic exotoxin type B in Escherichia coli . Infect. Immun. 56 , 1665-1667.
11. Burns, E.H., Marciel, A.M., and Musser, J.M. (1996). Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect. Immun. 64 , 4744-4750. (Pubitemid 26357087)
12. Carapetis, J., Steer, A., Mulholland, E., and Weber, M. (2005). The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5 , 685-694. (Pubitemid 41505357)
13. Carroll, R.K. and Musser, J.M. (2011). From transcription to activation: how group A streptococcus, the fl esh-eating pathogen, regulates SpeB cysteine protease production. Mol. Microbiol. 81 , 588-601.
14. Casadevall, A. and Pirofski, L.-A. (1999). Host-pathogen interactions: redefi ning the basic concepts of virulence and pathogenicity. Infect. Immun. 67 , 3703-3713. (Pubitemid 29356981)
15. Chaussee, M.S., Gerlach, D., Yu, C.-E., and Ferretti, J.J. (1993). Inactivation of the streptococcal erythrogenic toxin B gene ( speB ) in Streptococcus pyogenes . Infect. Immun. 61 , 3719-3723. (Pubitemid 23260042)
16. Cole, J.N., McArthur, J.D., McKay, F.C., Sanderson-Smith, M.L., Cork, A.J., Ranson, M., Rohde, M., Itzek, A., Sun, H., Ginsburg, D., et al. (2006) Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 20 , 1745-1747.
17. Collin, M. and Olsén, A. (2001a). EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 20 , 3046-3055. (Pubitemid 32611992)
18. Collin, M. and Olsén, A. (2001b). Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect. Immun. 69 , 7187-7189. (Pubitemid 32995485)
19. Collin, M. and Olsén, A. (2003). Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes . Infect. Immun. 71 , 2983-2992 (Pubitemid 36637518)
20. Collin, M., Svensson, M.D., Sj ö holm, A.G., Jensenius, J.C., Sj ö bring, U., and Olsén, A. (2002). EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect. Immun. 70 , 6646-6651. (Pubitemid 35387893)
21. Connolly, K., Roberts, A., and Holder, R. (2011). Dispersal of group A streptococcal biofi lms by the cysteine protease SpeB leads to increased disease severity in a murine model. PLoS ONE 6, e18984.
22. Darenberg, J., Luca-Harari, B., Jasir, A., Sandgren, A., Pettersson, H., Schalén, C., Norgren, M., Romanus, V., Norrby-Teglund, A., and Normark, B.H. (2007). Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45 , 450-458. (Pubitemid 47204461)
23. Doran, J., Nomizu, M., Takebe, S., Menard, R., Griffi th, D., and Ziomek, E. (1999). Autocatalytic processing of the streptococcal cysteine protease zymogen: processing mechanism and characterization of the autoproteolytic cleavage sites. Eur. J. Biochem. 263 , 145-151. (Pubitemid 29313849)
24. Egesten, A., Olin, A.I., Linge, H.M., Yadav, M., Mörgelin, M., Karlsson, A., and Collin, M. (2009). SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines. PLoS ONE 4 , e4769.
25. Elliott, S. (1945). A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type-specifi c M antigen. J. Exp. Med. 81 , 573-592.
26. Elliott, S. (1950). The crystallization and serological differentiation of a streptococcal proteinase and its precursor. J. Exp. Med. 92 , 201-219.
27. Elliott, S. and Dole, V. (1947). An inactive precursor of streptococcal proteinase. J. Exp. Med. 85 , 305-320.
28. Eriksson, A. and Norgren, M. (2003). Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect. Immun. 71 , 211-217. (Pubitemid 36026022)
29. Gerlach, D., Knöll, H., Köhler, W., Ozegowski, J.-H., and Hribalova, V. (1983). Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 225 , 221-233. (Pubitemid 14238039)
30. Gerlach, D., Reichardt, W., Fleischer, B., and Schmidt, K. (1994). Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase). Zentralbl. Bakteriol. 280 , 507-514. (Pubitemid 2068449)
31. Gubba, S., Cipriano, V., and Musser, J.M. (2000). Replacement of histidine 340 with alanine inactivates the group A Streptococcus extracellular cysteine protease virulence factor. Infect. Immun. 68 , 3716-3719. (Pubitemid 30340479)
32. Gubba, S., Low, D.E., and Musser, J.M. (1998). Expression and characterization of group A Streptococcus extracellular cysteine protease recombinant mutant proteins and documentation of seroconversion during human invasive disease episodes. Infect. Immun. 66 , 765-770. (Pubitemid 28074225)
33. Herwald, H., Collin, M., Müller-Esterl, W., and Björck, L. (1996). Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J. Exp. Med. 184 , 665-673. (Pubitemid 26324120)
34. Holm, S.E., Norrby, A., Bergholm, A.-M., and Norgren, M. (1992). Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J. Infect. Dis. 166 , 31-37.
35. Hyt ö nen, J., Haataja, S., Gerlach, D., Podbielski, A., and Finne, J. (2001). The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity. Mol. Microbiol. 39 , 512-519 (Pubitemid 32113520)
36. Kagawa, T., Cooney, J., Baker, H., McSweeney, S., Liu, M., Gubba, S., Musser, J., and Baker, E. (2000). Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc. Natl. Acad. Sci. USA 97 , 2235-2240. (Pubitemid 30134052)
37. Kagawa, T.F., O ' Toole, P.W., and Cooney, J.C. (2005). SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes . Mol. Microbiol. 57 , 650-666. (Pubitemid 41025949)
38. Kansal, R., McGeer, A., Low, D., Norrby-Teglund, A., and Kotb, M. (2000). Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68 , 6362-6369.
39. Kapur, V., Maffei, J., Greer, R., Li, L.-L., Adams, G., and Musser, J. (1994). Vaccination with streptococcal extracellular cysteine proteinase (interleukin-1 β convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathog. 16 , 443-450.
40. Kapur, V., Majesky, M.W., Li, L.L., Black, R.A., and Musser, J.M. (1993a). Cleavage of interleukin 1 beta (IL-1 β ) precursor to produce active IL-1 β by a conserved extracellular cysteine protease from Streptococcus pyogenes . Proc. Natl. Acad. Sci. USA 90 , 7676-7680. (Pubitemid 23250013)
41. Kapur, V., Topouzis, S., Majesky, M., Li, L.-L., Hamrick, M., Hamill, R., Patti, J., and Musser, J. (1993b). A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fi bronectin and degrades vitronectin. Microb. Pathog. 15 , 327-346. (Pubitemid 24107438)
42. Kazmi, S.U., Kansal, R., Aziz, R.K., Hooshdaran, M., Norrby- Teglund, A., Low, D.E., Halim, A.B., and Kotb, M. (2001). Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo . Infect. Immun. 69 , 4988-4995. (Pubitemid 32674482)
43. Kuo, C., Wu, J., Lin, K., Tsai, P., Lee, S., Jin, Y., Lei, H., and Lin, Y. (1998). Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect. Immun. 66 , 3931-3935. (Pubitemid 28347857)
44. Kuo, C.-F., Lin, Y.-S., Chuang, W.-J., Wu, J.-J., and Tsao, N. (2008). Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect. Immun. 76 , 1163-1169. (Pubitemid 351428077)
45. Liu, T.-Y. and Elliott, S. (1965a). Activation of streptococcal proteinase and its zymogen by bacterial cell walls. Nature 206 , 33-34.
46. Liu, T.-Y. and Elliott, S. (1965b). Streptococcal proteinase: the zymogen to enzyme transformation. J. Biol. Chem. 240 , 1138-1142.
47. Liu, T.-Y., Neumann, N., Elliott, S., Moore, S., and Stein, W. (1963). Chemical properties of streptococcal proteinase and its zymogen. J. Biol. Chem. 238 , 251-256.
48. Liu, T.-Y., Nomura, N., Jonsson, E.K., and Wallace, B.G. (1969). Streptococcal proteinase-catalyzed hydrolysis of some ester and amide substrates. J. Biol. Chem. 244 , 5745-5756.
49. Luca-Harari, B., Darenberg, J., Neal, S., Siljander, T., Strakova, L., Tanna, A., Creti, R., Ekelund, K., Koliou, M., Tassios, P.T., et al. (2009). Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47 , 1155-1165.
50. Lukomski, S., Burns, E., Wyde, P., Podbielski, A., Rurangirwa, J., Moore-Poveda, D., and Musser, J. (1998). Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect. Immun. 66 , 771-776. (Pubitemid 28074226)
51. Lukomski, S., Montgomery, C.A., Rurangirwa, J., Geske, R.S., Barrish, J.P., Adams, G.J., and Musser, J.M. (1999). Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect. Immun. 67 , 1779-1788. (Pubitemid 29144397)
52. Lukomski, S., Sreevatsan, S., Amberg, A., Reichardt, W., Woischnik, M., Podbielski, A., and Musser, J. (1997). Inactivation of Streptococcus pyogenes extracellular cysteine protease signifi-cantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99 , 2574-2580 (Pubitemid 27259803)
53. Lyon, W.R. and Caparon, M.G. (2004). Role for serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S. Infect. Immun. 72 , 1618-1625. (Pubitemid 38263785)
54. Matsuka, Y.V., Pillai, S., Gubba, S., Musser, J.M., and Olmsted, S.B. (1999). Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity. Infect. Immun. 67 , 4326-4333. (Pubitemid 29400403)
55. Meinert Niclasen, L., Olsen, J.G., Dagil, R., Qing, Z., S ø rensen, O.E., and Kragelund, B.B. (2011). Streptococcal pyogenic exotoxin B (SpeB) boosts the contact system via binding of α -1 antitrypsin. Biochem. J. 434 , 123-132.
56. Musser, J.M., Stockbauer, K., Kapur, V., and Rudgers, G.W. (1996). Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1 β convertase) alters proteolytic activity and ablates zymogen processing. Infect. Immun. 64 , 1913-1917. (Pubitemid 26165646)
57. Navarre, W.W. and Schneewind, O. (1999). Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63 , 174-229. (Pubitemid 29116092)
58. Nelson, D., Potempa, J., Kordula, T., and Travis, J. (1999). Purifi cation and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis . Evidence for a role in the inactivation of human α 1 -proteinase inhibitor. J. Biol. Chem. 274, 12245-12251.
59. Nizet, V. (2007). Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120 , 13-22. (Pubitemid 46990514)
60. Nomizu, M., Pietrzynski, G., Kato, T., Lachance, P., Ménard, R., and Ziomek, E. (2001). Substrate specifi city of the streptococcal cysteine protease. J. Biol. Chem. 276 , 44551-44556.
61. Nooh, M.M., Aziz, R.K., Kotb, M., Eroshkin, A., Chuang, W.-J., Proft, T., and Kansal, R. (2006). Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J. Biol. Chem. 281 , 35281-35288. (Pubitemid 46036566)
62. Nyberg, P., Rasmussen, M., and Bj ö rck, L. (2004a). α 2- Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J. Biol. Chem. 279 , 52820-52823. (Pubitemid 40051781)
63. Nyberg, P., Rasmussen, M., Pawel-Rammingen von, U., and Björck, L. (2004b). SpeB modulates fi bronectin-dependent internalization of Streptococcus pyogenes by effi cient proteolysis of cell-wall-anchored protein F1. Microbiology (Reading) 150 , 1559-1569. (Pubitemid 38750140)
64. Olsen, J.G., Dagil, R., Niclasen, L.M., S ø rensen, O.E., and Kragelund, B.B. (2009). Structure of the mature streptococcal cysteine protease exotoxin mSpeB in its active dimeric form. J. Mol. Biol. 393 , 693-703.
65. Olsen, R.J. and Musser, J.M. (2010). Molecular pathogenesis of necrotizing fasciitis. Annu. Rev. Pathol. 5 , 1-31
66. Olsen, R.J., Sitkiewicz, I., Ayeras, A.A., Gonulal, V.E., Cantu, C., Beres, S.B., Green, N.M., Lei, B., Humbird, T., Greaver, J., et al. (2010). Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc. Natl. Acad. Sci. USA 107 , 888-893.
67. Pinkney, M., Kapur, V., Smith, J., Weller, U., Palmer, M., Glanville, M., Messner, M., Musser, J.M., Bhakdi, S., and Kehoe, M.A. (1995). Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease. Infect. Immun. 63 , 2776-2779.
68. Raeder, R., Harokopakis, E., Hollingshead, S., and Boyle, M. (2000). Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect. Immun. 68 , 744-751. (Pubitemid 30056532)
69. Raeder, R., Woischnik, M., Podbielski, A., and Boyle, M. (1998). A secreted streptococcal cysteine protease can cleave a surfaceexpressed M1 protein and alter the immunoglobulin binding properties. Res. Microbiol. 149 , 539-548. (Pubitemid 29155314)
70. Reid, S.D., Montgomery, A.G., Voyich, J.M., DeLeo, F.R., Lei, B., Ireland, R.M., Green, N.M., Liu, M., Lukomski, S., and Musser, J.M. (2003). Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins. Infect. Immun. 71 , 7043-7052. (Pubitemid 37475336)
71. Schmidtchen, A., Frick, I.M., and Bj ö rck, L. (2001). Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial α -defensin. Mol. Microbiol. 39 , 708-713. (Pubitemid 32162156)
72. Shanley, T., Schrier, D., Kapur, V., Kehoe, M., Musser, J., and Ward, P. (1996). Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect. Immun. 64 , 870-877. (Pubitemid 26065561)
73. Stevens, D. (2003). Group A streptococcal sepsis. Curr. Infect. Dis. Rep. 5 , 379-386.
74. Stockbauer, K.E., Magoun, L., Liu, M., Burns, E.H., Gubba, S., Renish, S., Pan, X., Bodary, S.C., Baker, E., Coburn, J., et al. (1999). A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins α v β 3 and α IIb β 3 . Proc. Natl. Acad. Sci. USA 96 , 242-247. (Pubitemid 29036084)
75. Svensson, M., Scaramuzzino, D., Sj ö bring, U., Olsén, A., Frank, C., and Bessen, D. (2000). Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol. Microbiol. 38 , 242-253.
76. Svensson, M.D., Sj ö bring, U., Luo, F., and Bessen, D.E. (2002). Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology (Reading) 148 , 3933-3945. (Pubitemid 36097455)
77. Tai, J., Kortt, A., Liu, T.-Y., and Elliott, S. (1976). Primary structure of streptococcal proteinase. J. Biol. Chem. 251 , 1955-1959.
78. Talkington, D., Schwartz, B., Black, C., Todd, J., Elliott, J., Breiman, R., and Facklam, R. (1993). Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61 , 3369-3374. (Pubitemid 23223428)
79. Tamura, F., Nakagawa, R., Akuta, T., Okamoto, S., Hamada, S., Maeda, H., Kawabata, S., and Akaike, T. (2004). Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B). Infect. Immun. 72 , 4836-4847 (Pubitemid 38989344)
80. Terao, Y., Mori, Y., Yamaguchi, M., Shimizu, Y., Ooe, K., Hamada, S., and Kawabata, S. (2008). Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J. Biol. Chem. 283 , 6253-6260.
81. Thornton, R.F., Kagawa, T.F., O ' Toole, P.W., and Cooney, J.C. (2010). The dissemination of C10 cysteine protease genes in Bacteroides fragilis by mobile genetic elements. BMC Microbiol. 10 , 122.
82. Tsai, P., Lin, Y., Kuo, C., Lei, H., and Wu, J. (1999). Group A streptococcus induces apoptosis in human epithelial cells. Infect. Immun. 67 , 4334-4339 (Pubitemid 29400404)
83. Tsao, N., Tsai, W., Lin, Y., Chuang, W., Wang, C., and Kuo, C. (2006). Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Biochem. Biophys. Res. Commun. 339 , 779-784. (Pubitemid 41772881)
84. Vinh, D.C. and Embil, J.M. (2005). Rapidly progressive soft tissue infections. Lancet Infect. Dis. 5 , 501-513. (Pubitemid 41022026)
85. Walker, M.J., Hollands, A., Sanderson-Smith, M.L., Cole, J.N., Kirk, J.K., Henningham, A., McArthur, J.D., Dinkla, K., Aziz, R.K., Kansal, R.G., et al. (2007). DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat. Med. 13 , 981-985. (Pubitemid 47222039)
86. Wang, C.C., Houng, H.-C., Chen, C.-L., Wang, P.-J., Kuo, C.-F., Lin, Y.-S., Wu, J.-J., Lin, M.T., Liu, C.-C., Huang, W., et al. (2009). Solution structure and backbone dynamics of streptopain: insight into diverse substrate specifi city. J. Biol. Chem. 284 , 10957-10967.
87. Watanabe, Y., Todome, Y., Ohkuni, H., Sakurada, S., Ishikawa, T., Yutsudo, T., Fischetti, V., and Zabriskie, J. (2002). Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Infect. Immun. 70 , 3944-3947. (Pubitemid 34666037)
88. Wei, L., Pandiripally, V., Gregory, E., Clymer, M., and Cue, D. (2005). Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes . Infect. Immun. 73 , 2040-2050. (Pubitemid 40470802)
89. Wexler, D.E. and Cleary, P.P. (1985). Purifi cation and characteristics of the streptococcal chemotactic factor inactivator. Infect. Immun. 50 , 757.
90. Woischnik, M., Buttaro, B., and Podbielski, A. (2000). Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci. Microb. Pathog. 28 , 221-226.
91. Wolf, B., Gibson, C., Kapur, V., Hussaini, I., Musser, J., and Gonias, S. (1994). Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J. Biol. Chem. 269 , 30682-30687. (Pubitemid 24376557)
92. Yang, D., Chen, Q., Hoover, D., Staley, P., Tucker, K., Lubkowski, J., and Oppenheim, J. (2003). Many chemokines including CCL20/MIP-3 α display antimicrobial activity. J. Leukoc. Biol. 74 , 448-455. (Pubitemid 38040406)
93. Yu, C.-N. and Ferretti, J. (1991). Frequency of the erythrogenic toxin B and C genes ( speB and speC ) among clinical isolates of group A streptococci. Infect. Immun. 59 , 211-215.